Diagnostic Performance Of 4D Dynamic LAFOV FDG-PET Acquisition for Differentiation of Residual Disease and Post-radiation Inflammation in Head Neck SCC Treated by Radiotherapy.
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This multicenter prospective observational study will evaluate the value of dynamic FDG-PET LAFOV imaging during the initial therapeutic assessment of a head and neck cancer 3 months after completion of curative radiotherapy.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18 lat i więcej
- •Rozpoznany rak płaskonabłonkowy głowy i szyi
- •Ukończona leczenie napromienianiem (radioterapia)
- •Możliwość wykonania zaawansowanego skanowania PET 3 miesiące po leczeniu
- •Wyrażenie zgody na uczestnictwo w badaniu
✗ Disqualifies
- •Uczulenie na substancję diagnostyczną (18F-FDG) lub jej składniki
- •Ciąża lub karmienie piersią
- •Historia raka górnego przewodu pokarmowego
- •Niepełna radioterapia
- •Odmowa uczestnictwa w badaniu
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 13, 2026
- Sex
- No restrictions
Locations (3)
Centre finistérien de radiothérapie et d'oncologie - site Clinique Pasteur
Brest, France
Centre finistérien de radiothérapie et d'oncologie - Site de l'hôpital La Cavale Blanche
Brest, France
CHU Brest
Brest, France
Trial contact
Ronan ABGRAL, Pr
Jean-Christophe LECLERE, Dr
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/14/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.